TGF-β1 latency associated peptide promotes remodeling of healing cutaneous wounds in the rat

Iranian Journal of Medical Sciences

Volumn 31, Issue 2, 2006, Pages 65-69

  Varedi, M ^a,c   Englander, E W ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Texas Medical Branch School of Medicine   (United States)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fibrosis; Latency associated peptide; TGF 1; Wound healing

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTIBODY; COLLAGEN TYPE 1; CYCLINE; LATENCY ASSOCIATED PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPIDERMIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SKIN INJURY; WESTERN BLOTTING; WOUND HEALING;

EID: 33744955987     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. nd New York. Plenum Press, 1996.
2. rd ed. Philadelphia, PA, Saunders, 1992.
3. Mohammed S, Pack AR. The effect of transforming growth factor-beta (TGF-β1) on wound healing, with or without barrier membrane. J Periodontal Res 1998; 33: 335-44.
4. Amento EP, Beck LS. TGF-β1 and wound healing. Ciba Found Symp 1991; 157: 115-29.
5. Lyons R, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 1990; 187: 467-73.
6. Quaglino D, Nanney LB, Kennedy R, Dividson JM. Localized effects of transforming growth factor-beta on extracellular matrix gene expression during wound healing excisional wound model. Lab Invest 1990; 63: 307-19.
7. Edwards DR, Murphy G, Reynolds JJ, et al. Transfroming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitors. EMBO J 1987; 6: 1899-904.
8. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc natl Acad Sci 1986; 83: 4167-77.
9. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994; 124: 401-4.
10. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction and myofibroblast. Wound Repaie Regen 2005; 13: 7-12.
11. Varedi M, Tredget EE, Ghahary A, Scott PG. Stress-relaxation and contraction of a collagen matrix induces expression of TGF-β and triggers apoptosis in dermal fibroblasts. Biochem Cell Biol 2000; 78: 427-36.
12. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998; 30: 1019-30.
13. Funato N, Moruyama K, Baba Y, Kuroda T. Evidence for apoptosis induction in myofibroblasts during palatal mucoperiosteal repair. J Dent Res 1999; 78: 1511-7.
14. Zhang HY, Phan SH. Inhibition of myofibroblasts apoptosis by TGF-β1. Am J Respir Cell Mol Biol 1999; 21: 658-65.
15. Shi Y, O'Brien JE, Fard A, Zalewski A. Transforming growth factor-beta1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol 1996; 16: 1298-305.
16. Sanders EJ, Varedi M, French AS. Cell proliferation in the gastrulating chick embryo: a study using Brdu incorporation and PCNA localization. Development 1993; 118: 389-99.
17. Liu W, Wang DR, Cao YL. TGF-β, a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 2004; 4:123-36.
18. Bullard KM, Longaker MT, Lorenz HP. Fetal wound healing current biology. World J Surg 2003; 27: 54-61.
19. Choudon T, Sugihara T, Igawa HH, et al. Keloid-derived fibroblasts are refractory to fas-mediated apoptosis and neutralization of autocrine TGF-β1 can abrogate this resistance. Am J Pathol 2000; 157: 1661-9.
20. Shah M, Foreman DM, Ferguson WJ. Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002.
21. Zhang Y, McCormick LL, Gilliam AC. Latency-associate peptide prevents skin fibrosis in murine sclerodermatous graft-versushost disease, a model for human scleroderma. J Inves Dermatol 2003; 121: 713-9.
22. Bottinger EP, Factor VM, Tsang ML, Weatherbee JA, et al. The recombinant proregion of transforming growth factor beta1(LAP) inhibits active transforming growth factor beta-1 in transgenic mice. Proc Natl Acad Sci 1999; 93: 5877-82.
23. Wakefield LM, Smith DM, Flanders K, Sporn MB. Latent transforming growth factor-β1 from human platelets: A high molecular weight complex containing precursor sequence. J Biol Chem 1988; 263: 7646-54.
24. Orlidge AA, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci 1989; 86: 4544-8.
25. Sato Y, Rifikin DB. Activation of latent transforming growth factor-β-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309-15.